On October 2, 2019, Adicet Bio, Inc. closed the transaction. The transaction included participation from 18 investors including new investors aMoon Fund., DSC Investment Inc. (KOSDAQ:A241520), Handok, Inc. (KOSE:A002390), Johnson & Johnson Innovation - JJDC, Inc., KB Investment Co., Ltd., OCI Enterprises, Inc., Regeneron Pharmaceuticals, Inc. (NasdaqGS:REGN), Samsung Venture Investment Corporation, SBI JI Innovation Advisory Ltd., and Vincos Limited, and existing investors including Novartis Venture Funds, OrbiMed Advisors, L.L.C., Pontifax Ltd. Representative from Johnson & Johnson Innovation - JJDC, Inc. and Yair Schindel from aMoon Fund will join company's board of directors.